Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
into the implementation of interventions to improve care for people with multiple long-term conditions in primary care, funded by the NIHR Applied Research Collaboration (ARC) East Midlands. The post will involve
-
, electrophysiology, and molecular biology, and be able to work both independently and collaboratively across multiple sites About you The ideal candidate will hold (or be close to obtaining) a PhD in a relevant life
-
and 4-year PhD programme, the van Geest MultiOmics facility, a NIHR Clinical Research Facility including a dedicated 3T MRI research scanner (BHF funded Siemens Vida with multinuclear capability) and
-
: Design and implement models for a knowledge graph as part of an R&D team. Research methods and techniques for populating the knowledge graph. Develop models or algorithms to facilitate risk identification
-
support to the NIHR Global Health Research Centre for Multiple Long-Term Conditions, working with our partnering organisations across the UK, India and Nepal to improve health outcomes worldwide. In
-
enable LLHRG to expand. This includes 20 new staff members across academic, teaching, research, community engagement and administrative positions, in addition to 12 new PhD students. This expanding team
-
England scheme which will enable LLHRG to expand. This includes 20 new staff members across academic, teaching, research, community engagement and administrative positions, in addition to 12 new PhD
-
be confident managing multiple priorities, leading a team, and using systems to support bookings, reporting, and service delivery. Your communication skills will be key, as you’ll liaise with students
-
organised, communicates well and enjoys the challenge of managing to fit multiple commitments in any given day for a very busy Director. You will be a skilled and insightful individual, ideally with
-
responsible for working with the EpRG to manage multiple studies within the research portfolio. These will include LifeMap QUEST, an NIHR i4i-funded clinical study to confirm the safety and tolerability of a